NXL

+ Watchlist + Portfolio

Nexalin Technology, Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.33
52-Week Range: $0.31 – $2.00
Market Cap: $7.29M
P/E (TTM): —
EPS (TTM): -0.46
Dividend Yield: —

Advanced Metrics

Price/Book: 4.79
PEG Ratio: —
Return on Equity: -240.25%
Return on Assets: -119.22%
Gross Margin: 86.16%
Operating Margin: -18479.69%
Profit Margin: 0.00%
Current Ratio: 1.25
Debt/Equity: —
Total Debt: $0.00
Free Cash Flow: $-2.53M
Revenue Growth: -82.80%
Earnings Growth: —
Enterprise Value: $6.27M

NXL Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$1.32M	$110.75K	$168.72K	$301.65K
Cost of Revenue	$363.21K	$25.69K	$36.59K	$61.37K
Gross Profit	$958.14K	$85.06K	$132.13K	$240.27K
Research & Development	—	$1.92M	$1.19M	$1.08M
Selling, General & Admin	$2.79M	$3.86M	$6.70M	$7.55M
Operating Expenses	$2.79M	$5.78M	$7.89M	$8.63M
Operating Income	-$1.83M	-$5.70M	-$7.75M	-$8.39M
EBITDA	-$1.83M	-$5.69M	-$7.74M	-$8.37M
Pretax Income	-$1.70M	-$4.65M	-$7.61M	-$8.22M
Income Tax	—	$0.00	$0.00	$0.00
Net Income	-$1.70M	-$4.65M	-$7.61M	-$8.22M
Diluted EPS	-0.30	-0.63	-0.83	-0.50
Diluted Shares	5.57M	7.36M	9.22M	16.39M

NXL Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$162.74K	$580.23K	$574.49K	$654.78K
Receivables	$4.88K	$9.37K	$13.04K	$81.57K
Inventory	$154.37K	$156.42K	$174.58K	$131.47K
Current Assets	$7.43M	$3.43M	$3.96M	$4.30M
Total Assets	$7.43M	$3.63M	$4.22M	$4.64M
Current Liabilities	$1.95M	$425.28K	$546.69K	$887.33K
Total Debt	$755.26K	$4.46K	$0.00	—
Total Liabilities	$1.95M	$425.28K	$546.69K	$887.33K
Retained Earnings	-$72.39M	-$77.04M	-$84.65M	-$92.87M
Shareholders' Equity	$5.48M	$3.21M	$3.68M	$3.75M
Working Capital	$5.48M	$3.00M	$3.41M	$3.41M
Net Debt	$537.26K	—	—	—

NXL Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$2.22M	-$3.84M	-$3.94M	-$4.96M
Capital Expenditure	—	-$109.28K	-$170.31K	-$96.86K
Free Cash Flow	-$2.22M	-$3.94M	-$4.11M	-$5.05M
Depreciation & Amortisation	$535.00	$4.25K	$15.11K	$21.54K
Stock-Based Compensation	$270.67K	$2.41M	$3.56M	$3.12M
Investing Cash Flow	-$6.79M	$4.45M	-$577.54K	-$131.99K
Financing Cash Flow	$8.51M	-$200.00K	$4.52M	$5.17M
Net Change in Cash	-$499.04K	$417.49K	-$5.75K	$80.30K

NXL Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$41.02K	$70.59K	$18.15K	$171.90K	$14.95K
Cost of Revenue	$13.56K	$22.84K	$3.95K	$21.03K	$1.82K
Gross Profit	$27.46K	$47.75K	$14.20K	$150.87K	$13.13K
Research & Development	$406.29K	$225.77K	$226.52K	$224.94K	$346.38K
Selling, General & Admin	$1.63M	$1.44M	$2.13M	$2.34M	$1.79M
Operating Expenses	$2.04M	$1.67M	$2.36M	$2.56M	$2.13M
Operating Income	-$2.01M	-$1.62M	-$2.35M	-$2.41M	-$2.12M
EBITDA	-$2.01M	-$1.62M	-$2.34M	-$2.41M	-$2.11M
Pretax Income	-$1.99M	-$1.58M	-$2.28M	-$2.38M	-$2.10M
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income	-$1.99M	-$1.58M	-$2.28M	-$2.38M	-$2.10M
Diluted EPS	-0.15	-0.10	-0.13	—	-0.11
Diluted Shares	13.31M	15.72M	17.79M	—	19.82M

NXL Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$622.03K	$431.32K	$590.08K	$654.78K	$1.21M
Receivables	$14.48K	$59.84K	$7.92K	$81.57K	$43.00K
Inventory	$175.25K	$172.97K	$160.22K	$131.47K	$179.49K
Current Assets	$2.62M	$6.27M	$4.82M	$4.30M	$3.29M
Total Assets	$2.90M	$6.56M	$5.13M	$4.64M	$3.69M
Current Liabilities	$574.74K	$600.58K	$357.52K	$887.33K	$808.36K
Total Liabilities	$574.74K	$600.58K	$357.52K	$887.33K	$808.36K
Retained Earnings	-$86.63M	-$88.21M	-$90.49M	-$92.87M	-$94.96M
Shareholders' Equity	$2.33M	$5.96M	$4.77M	$3.75M	$2.89M
Working Capital	$2.05M	$5.67M	$4.46M	$3.41M	$2.48M

NXL Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$1.43M	-$917.16K	-$1.47M	-$1.15M	-$1.71M
Capital Expenditure	-$23.58K	-$20.48K	-$19.16K	-$33.64K	-$79.27K
Free Cash Flow	-$1.45M	-$937.64K	-$1.49M	-$1.18M	-$1.79M
Depreciation & Amortisation	$4.79K	$5.13K	$5.47K	$6.15K	$10.84K
Stock-Based Compensation	$636.84K	$572.10K	$1.08M	$831.53K	$478.61K
Investing Cash Flow	$1.47M	-$3.92M	$1.63M	$689.18K	$1.51M
Financing Cash Flow	$0.00	$4.65M	$0.00	$523.55K	$756.42K
Net Change in Cash	$47.54K	-$190.71K	$158.75K	$64.71K	$553.11K

Market Snapshot

About

Nexalin Technology, Inc. develops neurostimulation medical devices for treating mental health conditions and chronic pain. The company focuses on non-invasive cranial electrical stimulation technology designed to restore brain chemistry balance. Nexalin markets its devices to healthcare providers and patients seeking alternative treatment options for conditions like anxiety, depression, and insomnia.